Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Synteract, a full-service, international CRO, announced that Karl Deonanan has joined as Chief Financial Officer to lead their Finance and Contracts Proposals organizations and Jack Shannon has joined as Chief Commercial Officer.
Tom Haag
Bill Byrom
CRF Health, a global provider of patient-centered eSource technology and service solutions, has announced the appointment of Tom Haag, Vice President, Quality Assurance and Bill Byrom, Vice President of Product Strategy & Innovation.
Syneos Health, a fully integrated biopharmaceutical solutions organization, has announced the appointment of Lisa van Capelle as Chief Human Resources Officer.
Ashfield, part of UDG Healthcare, an international healthcare services provider, has announced the appointment of Doug Burcin as President of Ashfield Healthcare Communications.
Bracket, a clinical trial technology and specialty services provider, announced the appointment of Michael P. Nolte as CEO who brings along years of experience as the former CEO of Influence Health.
Business News
CluePoints, a provider of RBM and Data Quality Oversight solutions for clinical trials, has been honored in this year’s Biotechnology Awards with the CluePoints solution being named the “Best Risk-Based Monitoring Solution”.
OmniComm Systems, Inc. has announced that it has been named to the 2018 OTCQX Best 50, a ranking of top-performing companies traded on the OTCQX Best Market last year for their 2017 performance.
Senior executives in manufacturing operations within large global corporations have selected the Thermo Fisher Scientific’s InSight wireless cold storage monitoring solution as the winner of the 2017 Manufacturing Leaders Innovation Award.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.